In addition, a higher level of EGR1 has been associated with relapsing AML respect to AML at diagnosis with a direct correlation with increased proliferation and enhanced RAF/MEK/ERK1/2 activation [45]. The gene discussed is MAPK3; the disease is acute myeloid leukemia.